C
Charles E. Murry
Researcher at University of Washington
Publications - 290
Citations - 46975
Charles E. Murry is an academic researcher from University of Washington. The author has contributed to research in topics: Induced pluripotent stem cell & Stem cell. The author has an hindex of 85, co-authored 270 publications receiving 43033 citations. Previous affiliations of Charles E. Murry include Duke University & Fred Hutchinson Cancer Research Center.
Papers
More filters
Journal ArticleDOI
New possibilities for prenatal diagnosis of muscular dystrophies: forced myogenesis with an adenoviral MyoD-vector.
P.A.M. Roest,Egbert Bakker,Frits J. Fallaux,Christine Verellen-Dumoulin,Charles E. Murry,Johan T. den Dunnen +5 more
Book ChapterDOI
What is Ischemic Preconditioning
TL;DR: This chapter shall describe the studies that led to the original report of the preconditioning phenomenon, review the effects of repeated, brief ischemic insults in other organs and compare their responses with that of the heart.
Journal ArticleDOI
Inducible CRISPR genome editing platform in naive human embryonic stem cells reveals JARID2 function in self-renewal.
Amy Ferreccio,Julie Mathieu,Damien Detraux,Logeshwaran Somasundaram,Christopher Cavanaugh,Bryce L. Sopher,Karin A. Fischer,Thomas Bello,Abdiasis M. Hussein,Shiri Levy,Savannah Cook,Sonia B. Sidhu,Filippo Artoni,Nathan J. Palpant,Hans Reinecke,Yuliang Wang,Patrick J. Paddison,Patrick J. Paddison,Charles E. Murry,Suman Jayadev,Carol B. Ware,Hannele Ruohola-Baker +21 more
TL;DR: The iCas9 line was utilized to study the epigenetic regulator, PRC2 in early human pluripotency and data suggest that JARID2 regulates PRC 2 in 2iL-I-F state and the lack ofPRC2 function in 5iLA state may be due to lack of sufficient JARid2 protein.
Journal ArticleDOI
Selective control of endothelial cell proliferation with a synthetic dimerizer of FGF receptor-1
TL;DR: The ability to selectively activate receptor subtypes should facilitate the study of signaling pathways in vitro and in vivo beyond what can be accomplished with nonselective natural ligands, and it may eventually permit stimulation of graft cell angiogenesis without driving overgrowth of host cells.
Journal ArticleDOI
Delta-1 Functionalized Hydrogel Promotes hESC-Cardiomyocyte Graft Proliferation and Maintains Heart Function Post-Injury.
TL;DR: The therapeutic approach of a Delta-1 functionalized hydrogel to reduce the cell dose required to achieve functional benefit after myocardial infarction by enhancing hESC-CM graft size and proliferation is demonstrated.